Tahghighi Azar, Foroumadi Alireza, Kabudanian-Ardestani Susan, Mahdian Seyed Mohammad Amin
Malaria and Vector Research Group, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.
J Arthropod Borne Dis. 2017 Mar 14;11(1):95-104. eCollection 2017 Mar.
Cutaneous Leishmaniasis (CL) is endemic in many tropical and subtropical regions of the world. Due to the prolonged duration of therapy, adverse effect and resistance to current drugs in the treatment of CL, the discovery of novel, efficient, and safe leishmanicidal drugs is required. The aims of the present study was to synthesis of new compounds based on the active compounds of 5-(5-nitrofuran-2-yl)- and 5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazole bearing the linear amino alcohol of 3-aminopropan-1-ol in the C-2 position of thiadiazole ring and evaluation of their activity against the promastigote and amastigote forms of .
Reaction between the solution of 5-(5-nitro heteroaryl)-2-chloro-1,3,4-thiadiazole and piperidin-4-ol in absolute ethanol was performed and the resulting products were evaluated against promastigotes form of with MTT assay and amastigote form of in murine peritoneal macrophages. In addition, the toxicity of these compounds was assessed against mouse peritoneal macrophages with MTT assay.
New synthetic compounds 5a-b showed moderate in vitro antileishmanial activity against promastigotes with IC values of 68.9 and 27μM, respectively. These compounds have also demonstrated a good antiamastigote activity in terms of amastigote number per macrophage, the percentage of macrophage infectivity and infectivity index.
Novel cyclic compounds 5a-b were synthesized and exhibited less antipromastigote and antiamastigote activity compared to linear analogues.
皮肤利什曼病(CL)在世界许多热带和亚热带地区流行。由于CL治疗疗程长、存在不良反应以及对现有药物产生耐药性,因此需要发现新型、高效且安全的杀利什曼原虫药物。本研究的目的是基于5-(5-硝基呋喃-2-基)-和5-(5-硝基噻吩-2-基)-1,3,4-噻二唑的活性化合物,在噻二唑环的C-2位带有3-氨基丙醇的线性氨基醇,合成新化合物,并评估它们对前鞭毛体和无鞭毛体形式的活性。
在无水乙醇中进行5-(5-硝基杂芳基)-2-氯-1,3,4-噻二唑溶液与哌啶-4-醇的反应,并用MTT法对所得产物针对前鞭毛体形式的[具体寄生虫名称未给出]以及小鼠腹腔巨噬细胞中无鞭毛体形式的[具体寄生虫名称未给出]进行评估。此外,用MTT法评估这些化合物对小鼠腹腔巨噬细胞的毒性。
新合成的化合物5a - b对[具体寄生虫名称未给出]前鞭毛体表现出中等程度的体外抗利什曼原虫活性,IC值分别为68.9和27μM。就每个巨噬细胞中的无鞭毛体数量、巨噬细胞感染率和感染指数而言,这些化合物也表现出良好的抗无鞭毛体活性。
合成了新型环状化合物5a - b,与线性类似物相比,其抗前鞭毛体和抗无鞭毛体活性较低。